EN DE

C&S Paper Co (002511) Fair Value & Analysis

Consumer Defensive · CN · Market cap 9.0B CNY

CS C&S Paper Co 002511 · SHE
Price¥7.27
Fair Value¥5.20
Upside-28.5%
Quality73/100
Watch C&S Paper Co for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 4.0% net margin
Low debt · generates free cash flow
1.46% dividend yield
Mixed vs. peers (6/14)
Narrow moat 33/100
Evidence: High Range ¥3.90 – ¥6.50 Share as image

Fair value as of: Jul 22, 2026

From 26 valuation models · updated 19 days ago

Share price +3.7% over the past month.

A solid business, but screening 28% overvalued on our models.

What matters now

  • A high-quality business (quality 73/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • The price sits above even our optimistic bull case (¥6.50). The favourable scenario is already priced in.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥33.15 ¥5.93 Fair Value ¥5.20 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.

How to read this chart

60‑month range ¥5.93 – ¥33.15 · fair‑value band ¥3.90 – ¥6.50 · the ¥7.27 price screens above the ¥5.20 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

C&S Paper Co (002511) currently trades at ¥7.27, while our model-based Fair Value estimate is ¥5.20, implying the stock looks roughly 28.5% overvalued today. The Quality Score stands at 73/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, C&S Paper Co generated revenue of 8.9B CNY at a net margin of 4.0%. Revenue grew 6.3% year over year. It earns a return on equity of 6.4%. The balance sheet holds a net cash position of 169M CNY. Fundamentals as of Jul 22, 2026

Our scenario range runs from ¥3.90 (bear case) to ¥6.50 (bull case); at ¥7.27, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 21% below its 52-week high and 13% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -28%, 002511 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF ¥11.70 ¥18.47 ¥29.29 80
Residual Income ¥3.28 ¥3.36 ¥3.31 76
Rev-Margin DCF ¥7.37 ¥10.31 ¥14.11 74
All 26 models by family
DCF Models
FCF DCF ¥11.78 ¥19.21 ¥31.53 38
Owner Earnings ¥6.24 ¥9.53 ¥14.97 31
5Y Revenue Exit ¥7.37 ¥10.26 ¥13.98 39
5Y EBITDA Exit ¥9.37 ¥14.36 ¥20.47 41
5Y P/E Exit ¥7.56 ¥10.65 ¥14.04 38
10Y Revenue Exit ¥8.72 ¥11.93 ¥16.46 36
10Y EBITDA Exit ¥10.12 ¥14.85 ¥21.74 37
10Y P/E Exit ¥8.95 ¥12.20 ¥16.51 35
Earnings-Based
Graham-Dodd ¥1.68 ¥7.62 ¥10.45 54
Lynch FV ¥1.99 ¥2.85 ¥3.70 50
PEG = 1.0 ¥1.99 ¥2.85 ¥3.70 46
EPV ¥4.86 ¥5.34 ¥5.75 59
Dividend Discount
Gordon GGM ¥0.7100 ¥1.41 ¥2.14 70
DDM Multi-Stage ¥0.7100 ¥1.22 ¥1.49 61
Multiples
P/E Multiple ¥3.90 ¥5.20 ¥6.50 63
P/S Multiple ¥3.16 ¥4.21 ¥5.26 58
P/B Multiple ¥3.16 ¥4.21 ¥5.26 55
EV/EBIT ¥6.54 ¥8.11 ¥9.67 53
EV/EBITDA ¥8.72 ¥11.01 ¥13.31 54
EV/Revenue ¥5.20 ¥6.63 ¥8.07 43
Asset-Based
NCAV (Graham) ¥2.12 ¥2.84 ¥4.24 50
Growth DCF
Growth DCF ¥11.70 ¥18.47 ¥29.29 80
Rev-Margin DCF ¥7.37 ¥10.31 ¥14.11 74
Economic Profit
Residual Income ¥3.28 ¥3.36 ¥3.31 76
ROIC Compounder ¥5.11 ¥6.20 ¥7.68 72
Growth Earnings
Growth-Adj P/E ¥3.23 ¥4.61 ¥5.99 68

Widest divergence: DCF Models (¥11.93) versus Dividend Discount (¥1.22). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 8.9B CNY
Revenue growth (YoY) +6.3%
Net margin 4.0%
Return on equity 6.4%
Free cash flow 1.1B CNY FY2025
P/E ratio 24.9
More key figures
Operating margin 6.7%
EPS (TTM) ¥0.2800
Dividend yield 1.5%
EPS growth (YoY) +60.0%
Net cash 169M CNY FY2024

Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 73/100

Of which business quality 73 · Market factors (momentum, volatility) 46

Profitability 45
Margins and returns on capital today
Quality Growth 65
Are margins and returns improving?
Cashflow 72
Earnings quality: real cash, not paper profit
Fin. Strength 93
Balance sheet, leverage, solvency risk
Investment 91
Disciplined investing over empire-building
Low Volatility 81
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 36
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

C&S Paper Co.,Ltd manufactures and sells household paper products in Mainland China. The company offers paper rolls, tissue boxes, facial tissues, scented paper handkerchiefs, wipes, non-woven products, personal care products, baby diapers, cotton tissues, etc.

Full company description

C&S Paper Co.,Ltd manufactures and sells household paper products in Mainland China. The company offers paper rolls, tissue boxes, facial tissues, scented paper handkerchiefs, wipes, non-woven products, personal care products, baby diapers, cotton tissues, etc. It also sells medical devices, disposable medical and hygiene products, disinfectants, kitchenware, sanitary ware, daily sundries, non-woven fabrics and products, wood pulp, auxiliary materials, packaging materials, and baby products, as well as provides warehousing services. In addition, the company engages in wholesale, retail, and online sales of food; plastic, rubber, and metal products; textiles; and cosmetics. Further, the company engages in import and export goods or technology. It provides products under the Jie Rou, Duo Lei Mi, Sun, Jie Shi Jia, Jie Rou Mian Zi, Yue Yi Rou, Xin Mian Chu Bai, and Rou Ke Shi brand name. C&S Paper Co.,Ltd is based in Zhongshan, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

C&S Paper Co reported revenue of ¥8.8B in FY2025 versus ¥9.1B in FY2021, a compound −1.0%/yr. Reported net income was ¥319M in FY2025, compounding −13.9%/yr from FY2021.

Growth Quality 62/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
8.8B CNY
Latest YoY
+7.7%
Avg. growth/yr (3Y)
+0.8%
Avg. growth/yr (5Y)
+2.3%
Avg. growth/yr (18Y)
+11.5%
Revenue −1.0%/yr
FY21 ¥9.1B
FY22 ¥8.6B
FY23 ¥9.8B
FY24 ¥8.2B
FY25 ¥8.8B
Net income −13.9%/yr
FY21 ¥581M
FY22 ¥350M
FY23 ¥333M
FY24 ¥77.2M
FY25 ¥319M

002511 screens 28% overvalued. Compare with The Procter & Gamble Company →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "C&S Paper Co Fair Value". https://www.fairvalue-calculator.com/stock/002511

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 73 · Top 25%
Fair Value upside −29% · Below median
Return on equity (TTM) 6% · Below median
Return on assets 4% · Above median
Net margin (TTM) 4% · Below median
Operating margin (TTM) 7% · Below median
Revenue growth 6% · Above median
Dividend yield (TTM) 1.5% · Below median
Debt / equity 0.01× · Lower than median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 24.9× · Pricier than median
P/B 1.64× · Pricier than median
P/S (TTM) 1.01× · Cheaper than median
P/FCF 1.3× · Pricier than median
EV/EBITDA 7.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 28
FUTURE 32 · sector 4
PAST 25 · sector 26
HEALTH 99 · sector 98
DIVIDEND 29 · sector 50

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare C&S Paper Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is C&S Paper Co (002511) overvalued or undervalued?
As of Jul 22, 2026, our model estimates a fair value of ¥5.20 versus a price of ¥7.27, about −28% (overvalued).
What is the fair value of 002511?
Our model-based fair value for C&S Paper Co is ¥5.20 (as of Jul 22, 2026), built from audited fundamentals. The current price is ¥7.27.
What is the quality score of 002511?
C&S Paper Co has a Quality Score of 73/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of C&S Paper Co (002511)?
C&S Paper Co reported trailing-twelve-month revenue of about 8.9B CNY (latest available figure, as of Jul 22, 2026).
What is the net profit margin of 002511?
The net profit margin of C&S Paper Co is about 4.0%, meaning it keeps roughly 4.0% of revenue as net income. Based on the latest reported figures.
Does C&S Paper Co pay a dividend?
C&S Paper Co currently shows a dividend yield of about 1.46% relative to its recent price (as of Jul 22, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track C&S Paper Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.